This article was originally published in The Gray Sheet
Files for a secondary offering of 2 mil. common shares by the company and a separate offering of 300,000 shares by a selling shareholder. The first human implant of the Ottawa, Ontario firm's HeartSaver ventricular assist device is expected by year-end, and proceeds from the offering are tabbed for continuing R&D, product development and commercialization. World Heart and the selling shareholder will grant overallotment options of 300,000 and 45,000 shares, respectively, to offering managers Merrill Lynch Canada, ScotiaMcLeod and CIBC Wood Gundy Securities
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.